Novo Benefits, a company which specialises in creating self-funded insurance solutions, has completed the acquisition of technology platform Allay.

The financial details of the transaction have not been made public.

Access deeper industry intelligence

Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.

Find out more

This acquisition is part of Novo Benefits’ strategy to bring automated modelling and quoting to self-funded, mid-market health plans.

Post-merger, Allay will be re-branded as Novo Connection in order better integrate it with Novo’s existing portfolio of products.

Allay’s online platform allows advisers to model out various self-funding strategies rather than hiring a team of in-house health actuaries.

It helps the advisers understand a group’s risk, customise plan designs, and plan components, and secure competitive stop-loss coverage to match the plan designs.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Novo Benefits president Michael Poelman said: “For over a decade, Novo Benefits has been focused on making health insurance more affordable.

“The Allay platform is a game-changer that will transform the way insurance is delivered in the mid-market.

“This asset purchase immediately enhances our ability to better serve our broker-partners and provides opportunity and scalability to grow in the digital world.”

Novo Connection sales regional vice president Spencer Brydon said: “Having knowledge of both companies, I see a perfect fit where we can blend Allay’s front-end technology with Novo Benefits’ experience and ability to design, implement and manage self-funded health plans.

“The platform eliminates barriers to self-funding by making it easier for advisors to build and underwrite high-performing health plans in a fraction of the time.”

Allay CEO Julien Emery shared: “With the assets of both entities combined, Novo is well-positioned to take Allay to the next level and deliver their existing service at scale.

“Having an in-house, technology-first strategy will help drive better health outcomes, lower costs, and a better experience for employers and employees across the country while providing greater efficiency and peace of mind for broker partners.”